[1]
B. Rojek and M. Wesołowski, “Evaluation of usefulness of CA and PCA for identificationof incompatibilities in the pharmaceutical phase”, Curr. Issues Pharm. Med. Sci., vol. 22, no. 4, pp. 49–57, Dec. 2009, Accessed: Jun. 07, 2025. [Online]. Available: https://czasopisma.umlub.pl/curipms/article/view/2820